Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Efficacy of Two Primaquine Dosing Regimens for the Radical Treatment of Plasmodium Vivax Malaria in Vanuatu and Solomon Islands

NCT01837992 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT01837992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01837992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Efficacy of Two Primaquine Dosing Regimens for the Radical Treatment of Plasmodium Vivax Malaria in Vanuatu and Solomon Islands
Lead sponsor
Menzies School of Health Research
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2013
Completion date
May 31, 2015
Enrollment
180 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

malaria